CeriBell (CBLL) to Release Earnings on Tuesday

CeriBell (NASDAQ:CBLL) is scheduled to announce its earnings results after the market closes on Tuesday, November 12th. Analysts expect the company to announce earnings of ($1.09) per share for the quarter. Investors that are interested in registering for the company’s conference call can do so using this link.

CeriBell Stock Performance

Shares of NASDAQ CBLL opened at $28.27 on Friday. CeriBell has a 52-week low of $23.00 and a 52-week high of $29.53.

Analyst Ratings Changes

Several research firms recently issued reports on CBLL. Canaccord Genuity Group initiated coverage on CeriBell in a research report on Tuesday, November 5th. They issued a “buy” rating and a $30.00 price objective on the stock. William Blair assumed coverage on CeriBell in a research report on Tuesday, November 5th. They set an “outperform” rating on the stock. Bank of America assumed coverage on CeriBell in a report on Tuesday, November 5th. They issued a “buy” rating and a $32.00 price objective for the company. TD Cowen initiated coverage on shares of CeriBell in a research note on Tuesday, November 5th. They set a “buy” rating and a $31.00 target price on the stock. Finally, JPMorgan Chase & Co. started coverage on shares of CeriBell in a research note on Tuesday, November 5th. They issued an “overweight” rating and a $32.00 price target for the company. Six research analysts have rated the stock with a buy rating, According to MarketBeat, the stock has a consensus rating of “Buy” and an average target price of $31.00.

About CeriBell

We are a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. We have developed the Ceribell System, a novel, point-of-care electroencephalography (“EEG”) platform specifically designed to address the unmet needs of patients in the acute care setting.